1. Home
  2. ELDN vs CPS Comparison

ELDN vs CPS Comparison

Compare ELDN & CPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELDN
  • CPS
  • Stock Information
  • Founded
  • ELDN 2004
  • CPS 1960
  • Country
  • ELDN United States
  • CPS United States
  • Employees
  • ELDN 31
  • CPS N/A
  • Industry
  • ELDN Biotechnology: Pharmaceutical Preparations
  • CPS Auto Parts:O.E.M.
  • Sector
  • ELDN Health Care
  • CPS Consumer Discretionary
  • Exchange
  • ELDN Nasdaq
  • CPS Nasdaq
  • Market Cap
  • ELDN 176.1M
  • CPS 250.0M
  • IPO Year
  • ELDN N/A
  • CPS N/A
  • Fundamental
  • Price
  • ELDN $2.99
  • CPS $12.18
  • Analyst Decision
  • ELDN Strong Buy
  • CPS
  • Analyst Count
  • ELDN 1
  • CPS 0
  • Target Price
  • ELDN $16.00
  • CPS N/A
  • AVG Volume (30 Days)
  • ELDN 249.0K
  • CPS 419.9K
  • Earning Date
  • ELDN 05-08-2025
  • CPS 05-01-2025
  • Dividend Yield
  • ELDN N/A
  • CPS N/A
  • EPS Growth
  • ELDN N/A
  • CPS N/A
  • EPS
  • ELDN N/A
  • CPS N/A
  • Revenue
  • ELDN N/A
  • CPS $2,730,893,000.00
  • Revenue This Year
  • ELDN N/A
  • CPS $5.20
  • Revenue Next Year
  • ELDN N/A
  • CPS $6.33
  • P/E Ratio
  • ELDN N/A
  • CPS N/A
  • Revenue Growth
  • ELDN N/A
  • CPS N/A
  • 52 Week Low
  • ELDN $1.55
  • CPS $10.38
  • 52 Week High
  • ELDN $5.54
  • CPS $17.76
  • Technical
  • Relative Strength Index (RSI)
  • ELDN 39.03
  • CPS 40.40
  • Support Level
  • ELDN $2.63
  • CPS $11.48
  • Resistance Level
  • ELDN $3.21
  • CPS $12.87
  • Average True Range (ATR)
  • ELDN 0.24
  • CPS 1.23
  • MACD
  • ELDN 0.03
  • CPS -0.22
  • Stochastic Oscillator
  • ELDN 45.24
  • CPS 32.09

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

About CPS Cooper-Standard Holdings Inc.

Cooper-Standard Holdings Inc is a supplier of rubber and resin products for the automotive industry. The company produces rubber and plastic sealings, fuel and brake lines, fluid transfer hoses, and anti-vibration systems used by original equipment manufacturers and replacement markets for passenger vehicles and light trucks. The largest customers include Ford, GM, FCA, Peugeot Citroen, and Volkswagen. Cooper Standard generates the majority of its revenue with its sealing systems products such as Fortrex, dynamic and static seals, stainless steel trims, flush glass systems, and variable extrusions.

Share on Social Networks: